Free Trial

Ardelyx (ARDX) News Today

Ardelyx logo
$3.91 -0.06 (-1.51%)
Closing price 04:00 PM Eastern
Extended Trading
$3.92 +0.01 (+0.38%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARDX Latest News

Ardelyx, Inc. stock logo
Voloridge Investment Management LLC Has $4.54 Million Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX)
Voloridge Investment Management LLC raised its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 24.6% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 895,748 shares of the biopharmaceutical company's stock after acquiring an additi
Ardelyx, Inc. stock logo
Ardelyx, Inc. (NASDAQ:ARDX) Shares Purchased by Two Sigma Investments LP
Two Sigma Investments LP boosted its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,141,777 shares of the biopharmaceutical company's st
Ardelyx, Inc. stock logo
Deutsche Bank AG Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX)
Deutsche Bank AG increased its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 25.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 327,900 shares of the biopharmaceutical company's stock
Ardelyx, Inc. stock logo
Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells $26,197.68 in Stock
Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) insider Laura A. Williams sold 6,421 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $4.08, for a total value of $26,197.68. Following the transaction, the insider now directly owns 402,583 shares in the company, valued at approximately $1,642,538.64. This trade represents a 1.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Ardelyx, Inc. stock logo
Millennium Management LLC Trims Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX)
Millennium Management LLC lowered its holdings in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 26.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,963,480 shares of the biopharmaceutical company's stock after selling 1,048,400 shares during the p
Ardelyx, Inc. stock logo
Two Seas Capital LP Makes New Investment in Ardelyx, Inc. (NASDAQ:ARDX)
Two Seas Capital LP purchased a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,855,337 shares of the biopharmaceutical comp
Ardelyx, Inc. stock logo
Point72 Asset Management L.P. Purchases New Position in Ardelyx, Inc. (NASDAQ:ARDX)
Point72 Asset Management L.P. purchased a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 1,333,810 shares of the biopharmaceutical
Ardelyx, Inc. stock logo
Sherbrooke Park Advisers LLC Acquires Shares of 66,623 Ardelyx, Inc. (NASDAQ:ARDX)
Sherbrooke Park Advisers LLC acquired a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 66,623 shares of the biopharmaceutical company's stock, valued at approximately
Ardelyx, Inc. stock logo
BNP Paribas Financial Markets Boosts Holdings in Ardelyx, Inc. (NASDAQ:ARDX)
BNP Paribas Financial Markets boosted its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 54.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 280,269 shares of the biopharmaceutical company's stock after
Ardelyx, Inc. stock logo
D. E. Shaw & Co. Inc. Buys 1,453,369 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
D. E. Shaw & Co. Inc. increased its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 9,499.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,468,668 shares of
Ardelyx, Inc. stock logo
The Manufacturers Life Insurance Company Sells 130,801 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
The Manufacturers Life Insurance Company lessened its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 52.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 117,123 shares of the biopharmaceutical c
Ardelyx, Inc. stock logo
Ardelyx (NASDAQ:ARDX) Reaches New 1-Year Low - Here's Why
Ardelyx (NASDAQ:ARDX) Sets New 1-Year Low - Should You Sell?
Ardelyx, Inc. stock logo
Janus Henderson Group PLC Buys 2,858,061 Shares of Ardelyx, Inc. (NASDAQ:ARDX)
Janus Henderson Group PLC raised its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 13.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,387,941 shares of th
Ardelyx, Inc. stock logo
Cubist Systematic Strategies LLC Takes $1.90 Million Position in Ardelyx, Inc. (NASDAQ:ARDX)
Cubist Systematic Strategies LLC acquired a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 375,467 shares of the biopharmaceutical company's stock, valued at a
Ardelyx, Inc. stock logo
Price T Rowe Associates Inc. MD Has $826,000 Stock Position in Ardelyx, Inc. (NASDAQ:ARDX)
Price T Rowe Associates Inc. MD lowered its stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 84.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 162,824 shares of the biopharmaceutical company's stock after selling 911,664 shares during th
Ardelyx, Inc. stock logo
Schonfeld Strategic Advisors LLC Cuts Stake in Ardelyx, Inc. (NASDAQ:ARDX)
Schonfeld Strategic Advisors LLC cut its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 56.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 131,200 shares of the biopharmaceutical company's stock after selling 169,684 shares during the period. Sc
Ardelyx, Inc. stock logo
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the ten research firms that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, seven have assigned a
Ardelyx, Inc. stock logo
126,530 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Acquired by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL purchased a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 126,530 shares of the biopharmaceutical company's stock, valued at approximately $642,
Ardelyx, Inc. stock logo
First Trust Advisors LP Has $1.36 Million Stock Position in Ardelyx, Inc. (NASDAQ:ARDX)
First Trust Advisors LP lessened its holdings in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 53.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 268,924 shares of the biopharmaceutical company's stock after se
Ardelyx, Inc. stock logo
Ardelyx (NASDAQ:ARDX) Shares Gap Up After Insider Buying Activity
Ardelyx (NASDAQ:ARDX) Shares Gap Up Following Insider Buying Activity
Ardelyx, Inc. stock logo
Algert Global LLC Invests $4.98 Million in Ardelyx, Inc. (NASDAQ:ARDX)
Algert Global LLC purchased a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 983,084 shares of the biopharmaceutical company's stock, valued at approxi
Ardelyx, Inc. stock logo
Raymond James Financial Inc. Makes New $930,000 Investment in Ardelyx, Inc. (NASDAQ:ARDX)
Raymond James Financial Inc. bought a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 183,490 shares of the biopharmaceutical company's stock, valued at approximately $930,000. Raymond James Fi
Ardelyx, Inc. stock logo
Ardelyx (NASDAQ:ARDX) Trading Down 8.4% on Analyst Downgrade
Ardelyx (NASDAQ:ARDX) Trading Down 8.4% on Analyst Downgrade
Ardelyx, Inc. stock logo
Wedbush Weighs in on Ardelyx's Q4 Earnings (NASDAQ:ARDX)
Ardelyx, Inc. (NASDAQ:ARDX - Free Report) - Equities research analysts at Wedbush boosted their Q4 2025 EPS estimates for Ardelyx in a report issued on Friday, May 2nd. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will post earnings of $0.01 per share for the quarter,
Scotiabank Remains a Buy on Ardelyx (ARDX)
Ardelyx, Inc. stock logo
Ardelyx (NASDAQ:ARDX) Announces Earnings Results
Ardelyx (NASDAQ:ARDX - Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.17) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.07). Ardelyx had a negative return on equity of 24.87% and a negative net margin of 11.73%. The business had revenue of $74.11 million for the quarter, compared to analyst estimates of $79.40 million. During the same quarter last year, the firm earned ($0.11) earnings per share. The firm's quarterly revenue was up 61.1% compared to the same quarter last year.
Ardelyx, Inc. stock logo
Hsbc Holdings PLC Acquires New Position in Ardelyx, Inc. (NASDAQ:ARDX)
Hsbc Holdings PLC acquired a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 281,764 shares of the biopharmaceutical company's stock, valued at approximately $1,423,0
Ardelyx, Inc. stock logo
Marshall Wace LLP Takes Position in Ardelyx, Inc. (NASDAQ:ARDX)
Marshall Wace LLP bought a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 114,819 shares of the biopharmaceutical comp
Ardelyx, Inc. stock logo
Ardelyx (NASDAQ:ARDX) Hits New 1-Year Low Following Weak Earnings
Ardelyx (NASDAQ:ARDX) Reaches New 52-Week Low Following Weak Earnings
Ardelyx, Inc. stock logo
Ardelyx (NASDAQ:ARDX) Cut to Outperform at Raymond James
Raymond James lowered Ardelyx from a "strong-buy" rating to an "outperform" rating and set a $11.00 price objective on the stock. in a research note on Friday.
Get Ardelyx News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter.

ARDX Media Mentions By Week

ARDX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARDX
News Sentiment

0.62

1.03

Average
Medical
News Sentiment

ARDX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARDX Articles
This Week

19

9

ARDX Articles
Average Week

Get Ardelyx News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ARDX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners